Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011;15(2):209.
doi: 10.1186/cc9991. Epub 2011 Mar 22.

Hypoxia-inducible factors and the prevention of acute organ injury

Samuel N Heyman  1 , Seymour Rosen, Christian Rosenberger
Affiliations
Review

Hypoxia-inducible factors and the prevention of acute organ injury

Samuel N Heyman et al. Crit Care. 2011.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
A schematic display of hypoxia-inducible factor (HIF) regulation and biological action. Prolyl-4 hydroxylases (PHDs) serve as oxygen sensors and under normoxic conditions promote degradation of HIF-α isoforms in the proteasome following binding with the ubiquitin ligase, Von-Hippel-Lindau protein (VHL). Hypoxia inhibits PHDs and leads to HIF-α accumulation with HIF-β, and the αβ heterodimer translocates into the nucleus, binds with hypoxia-response elements (HRE) and activates numerous genes important in cell metabolism, proliferation and survival. Many of these genes play a central role in injury tolerance and promotion of tissue oxygenation, such as erythropoietin (EPO), vascular endothelial growth factor (VEGF), inducible NO synthase (iNOS), heme oxygenase (HO)-1, glucose transporter-1, or carbonic anhydrase (CA)-9. Underscored is the inactivation of the HIF-HRE axis by hypoxia, which can be mimicked by carbon monoxide (functional anemia) or by transition metals like cobaltous chloride. Hypoxia-mimetic PHD inhibitors (PHD-I) are potent newly developed measures in the induction of the HIF-HRE axis. For simplicity, numerous additional factors involved in HIF regulation and action are not included in this cartoon and the reader is referred to comprehensive reviews such as references [3,12].
See this image and copyright information in PMC

References

    1. Bernhardt WM, Eckardt KU. Physiological basis for the use of erythropoietin in critically ill patients at risk for acute kidney injury. Curr Opin Crit Care. 2008;14:621–626. doi: 10.1097/MCC.0b013e328317ee82. - DOI - PubMed
    1. Semenza G. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol. 2002;64:993–998. doi: 10.1016/S0006-2952(02)01168-1. - DOI - PubMed
    1. Gunaratnam L, Bonventre JV. HIF in kidney disease and development. J Am Soc Nephrol. 2009;20:1877–1887. doi: 10.1681/ASN.2008070804. - DOI - PubMed
    1. Rosenberger C, Rosen S, Heyman S. Current understanding of HIF in renal disease. Kidney Blood Press Res. 2005;28:325–340. doi: 10.1159/000090187. - DOI - PubMed
    1. Willam C, Maxwell PH, Nichols L. et al.HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation. J Mol Cell Cardiol. 2006;41:68–77. doi: 10.1016/j.yjmcc.2006.04.009. - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources